Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

847 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Tomita N, Kodama F, Sakai R, Koharasawa H, Hattori M, Taguchi J, Fujita H, Tanabe J, Fujisawa S, Fukawa H, Harano H, Kanamori H, Miyashita H, Matsuzaki M, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Tomita N, et al. Among authors: kanamori h. Leuk Lymphoma. 2000 Jul;38(3-4):335-43. doi: 10.3109/10428190009087024. Leuk Lymphoma. 2000. PMID: 10830740
[VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma].
Tanabe J, Kanamori H, Matsuzaki M, Motomura S, Mohri H, Okubo T, Maruta A, Kodama F. Tanabe J, et al. Among authors: kanamori h. Nihon Ronen Igakkai Zasshi. 1994 Feb;31(2):135-41. doi: 10.3143/geriatrics.31.135. Nihon Ronen Igakkai Zasshi. 1994. PMID: 7517465 Free article. Japanese.
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M, Motomura S, Tomita N, Taguchi J, Tanabe J, Sakai R, Fujisawa S, Fukawa H, Kanamori H, Mouri H, Maruta A, Kodama F, Okubo T. Hattori M, et al. Among authors: kanamori h. Rinsho Ketsueki. 1996 Feb;37(2):101-8. Rinsho Ketsueki. 1996. PMID: 8852026 Japanese.
Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adults.
Fujisawa S, Maruta A, Motomura S, Fukawa H, Kanamori H, Ogawa K, Matsuzaki M, Miyashita H, Harano H, Murata T, Sakai R, Mohri H, Kodama F, Okubo T. Fujisawa S, et al. Among authors: kanamori h. Leuk Lymphoma. 1998 Mar;29(1-2):161-70. doi: 10.3109/10428199809058391. Leuk Lymphoma. 1998. PMID: 9638985 Clinical Trial.
847 results